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Alterations in cellular 
and organellar phospholipid 
compositions of HepG2 cells 
during cell growth
Tokuji Tsuji1, Shin‑ya Morita1*, Yoshinobu Nakamura1, Yoshito Ikeda1, Taiho Kambe2 & 
Tomohiro Terada1
The human hepatoblastoma cell line, HepG2, has been used for investigating a wide variety of 
physiological and pathophysiological processes. However, less information is available about the 
phospholipid metabolism in HepG2 cells. In the present report, to clarify the relationship between 
cell growth and phospholipid metabolism in HepG2 cells, we examined the phospholipid class 
compositions of the cells and their intracellular organelles by using enzymatic fluorometric methods. 
In HepG2 cells, the ratios of all phospholipid classes, but not the ratio of cholesterol, markedly 
changed with cell growth. Of note, depending on cell growth, the phosphatidic acid (PA) ratio 
increased and phosphatidylcholine (PC) ratio decreased in the nuclear membranes, the sphingomyelin 
(SM) ratio increased in the microsomal membranes, and the phosphatidylethanolamine (PE) 
ratio increased and the phosphatidylserine (PS) ratio decreased in the mitochondrial membranes. 
Moreover, the mRNA expression levels of enzymes related to PC, PE, PS, PA, SM and cardiolipin 
syntheses changed during cell growth. We suggest that the phospholipid class compositions of 
organellar membranes are tightly regulated by cell growth. These findings provide a basis for future 
investigations of cancer cell growth and lipid metabolism.
Liver cancer is the seventh most commonly diagnosed cancer and the third leading cause of cancer death world-
wide, and mainly includes hepatocellular carcinoma, cholangiocarcinoma and  hepatoblastoma1,2. Hepatoblas-
toma is the most common malignant hepatic tumor in pediatrics and is considered to originate from hepatoblasts 
or embryonic liver progenitor  cells3. The HepG2 cell line was originally isolated from primary hepatoblastoma of 
a 15-year-old Caucasian male, and exhibits epithelial-like  morphology4–6. In addition to cancer studies, HepG2 
cells have been widely used as an in vitro liver model for lipid and lipoprotein metabolism, bile salt metabolism, 
drug metabolism, toxicity, biliary excretion, insulin resistance and infection  studies5,7–15.
In recent years, there is growing evidence for a relationship between hepatic dysfunction and alterations 
in membrane phospholipid  compositions16,17. Phospholipids are essential components of bilayer membranes 
in mammalian cells, and well known to be involved in numerous cellular processes, including cell growth, 
mitochondrial energy production, apoptosis, membrane trafficking, autophagy and intracellular  signaling18–23. 
Phospholipids are divided into glycerophospholipids and sphingophospholipids based on their backbone struc-
tures. Depending on the head group structures, glycerophospholipids are further classified into phosphatidyl-
choline (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidic acid (PA), phosphati-
dylinositol (PI), phosphatidylglycerol (PG) and cardiolipin (CL)24. Sphingophospholipids have a sphingosine 
backbone, and sphingomyelin (SM) is the most predominant sphingophospholipid in mammalian cells and 
plasma  lipoproteins24. In mammalian cell membranes, cholesterol is an essential regulator of membrane physical 
properties such as  fluidity25.
In mammalian cells, biosynthesis of phospholipids mainly occurs at the endoplasmic reticulum (ER), 
Golgi apparatus and mitochondria via the actions of numerous enzymes (Supplementary Fig. S1). The major-
ity of hepatocellular PC molecules are synthesized from phosphocholine through the CDP-choline pathway, 
including CTP:phosphocholine cytidylyltransferase (CCT) and CDP-choline:diacylglycerol cholinephospho-
transferase (CPT)26. In addition to the CDP-choline pathway, PE N-methyltransferase (PEMT) catalyzes the 
methylation of PE and produces approximately 30% of PC in liver  cells15,26. In the CDP-ethanolamine pathway 
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for PE biosynthesis, a sequence of reactions catalyzed by CTP:phosphoethanolamine cytidylyltransferase 
(ECT) and CDP-ethanolamine:diacylglycerol ethanolaminephosphotransferase (EPT) produces PE from 
 phosphoethanolamine26. PS decarboxylase (PSD) is an enzyme to synthesize PE from PS in  mitochondria26,27. PS 
synthase 1 (PSS1) and 2 (PSS2) are responsible for the exchange of l-serine with polar head groups of PC and PE, 
 respectively26,28. Diacylglycerol kinase (DGK) catalyzes the phosphorylation of diacylglycerol (DG) to produce 
 PA18. Phospholipase D1 (PLD1) and D2 (PLD2) are enzymes for PA production from  PC29,30. PA is an essential 
substrate of CDP-DG synthase 1 (CDS1) or 2 (CDS2) to generate CDP-DG, which is an intermediate to produce 
PI via PI synthase (PIS) in the  ER31,32. CDP-DG is also necessary for PG and CL biosynthesis in the mitochondrial 
membrane via phosphatidylglycerophosphate synthase 1 (PGS1) and CL synthase (CLS),  respectively33–35. Serine 
palmitoyltransferase (SPT) catalyzes the first committed step in ceramide synthesis. Lastly, SM is produced by the 
transfer of phosphocholine from PC to ceramide, which predominantly occurs at the luminal side of trans-Golgi 
membranes by SM synthase 1 (SMS1) or at the plasma membranes by SM synthase 2 (SMS2)36.
The functions and morphology of HepG2 cells change with cell  growth5,9,37. The phospholipid composition 
affects membrane shape, activity and localization of membrane proteins, cell growth and cell  migration18,21,38. 
Therefore, in HepG2 cells, the changes in phospholipid compositions that occur during cell growth are predicted 
to affect cellular functions. However, the alterations of phospholipid class composition in HepG2 cells and their 
intracellular organelles during cell growth have not been investigated because of the difficulty in quantifying low 
levels of phospholipid classes in sparse cells and isolated intracellular organelles by using conventional methods. 
Recently, we have developed fluorometric assays for all major phospholipid classes including PC, PE, PS, PI, 
PA, PG, CL and SM, using combinations of specific enzymes and Amplex Red, which enable simple, sensitive 
(pico-molar range) and high-throughput  quantification24,39–44. In the present study, we assessed the effects of cell 
growth on the phospholipid class compositions in HepG2 cells and their nuclei, microsomes and mitochondria 
using our enzymatic assays, and investigated the changes in mRNA expression of phospholipid synthesis-related 
enzymes during cell growth.
Results and discussion
Growth of HepG2 cells. To observe cell growth, HepG2 cells seeded at a density of 5.0 × 104 cells/cm2 were 
cultured in DMEM containing 10% FBS for up to 14 days. Cell growth was evaluated by measuring cellular DNA 
or protein. Growth curve analyses demonstrated that HepG2 cells grew in the logarithmic phase from Day 2 to 
Day 5 (Fig. 1a,b). Then, the cell growth rate gradually decreased, and the cells entered into stationary phase at 
Day 8 under the experimental conditions. Figure 1c shows images of HepG2 cells at Day 3 in the early logarith-
mic phase, at Day 6 in the late logarithmic phase and at Day 12 in the stationary phase. HepG2 cells grew as a 
monolayer at Day 3, whereas the cells were overconfluent as a multilayer at Day 12.
Phospholipid composition in HepG2 cells in different growth phases. The HepG2 cell line is one 
of the most widely used models for studying hepatic lipid  metabolism5,12, whereas the basic information about 
the phospholipid compositions of the cellular membranes is scarce. Previously, we have found that the contents 
of phospholipid classes change in human embryonic kidney HEK293 cells depending on the cell  density44. In the 
present study, we investigated whether the lipid contents in HepG2 cells were altered during cell growth. Using 
the enzymatic fluorometric methods that we developed previously, we examined the contents of all phospholipid 
classes and cholesterol in HepG2 cells at Day 3 in the early logarithmic phase, at Day 6 in the late logarithmic 
phase and at Day 12 in the stationary phase of cell growth (Supplementary Table S1). To evaluate changes in 
phospholipid class composition of whole cells, we determined the content ratio of each phospholipid class to 
total phospholipids (TPL). As a result, the cellular PC/TPL and PI/TPL ratios increased from Day 3 to Day 6, and 
the SM/TPL ratio at Day 12 was significantly higher than that at Day 3 (Fig. 2a,e,g). On the other hand, the PE/
TPL, PS/TPL, PA/TPL and (PG + CL)/TPL ratios decreased with cell growth (Fig. 2b,c,d,f). Although the ratios 
of all phospholipid classes markedly changed with cell growth, the cholesterol/TPL ratio and the TPL content 
were not significantly different among Day 3, Day 6 and Day 12 (Fig. 2h,i). In addition, the phospholipid compo-
sitions of the cells were compared at Day 3, Day 6 and Day 12. The ratios of the phospholipid classes were in the 
order PC > PE > PA > PS > SM ≥ PI > PG + CL at Day 3 in the early logarithmic phase of cell growth, whereas the 
ratios of PI and SM became higher than those of PS and PA at Day 12 in the stationary phase (Fig. 2j).
In addition, we examined the cell growth-associated changes in phospholipid class and cholesterol composi-
tion in human PLC/PRF/5 hepatoma cells, which have been established from the liver of a patient with primary 
liver cell carcinoma and produce hepatitis B surface  antigen45. Similar to HepG2 cells, PLC/PRF/5 cells increased 
the PC/TPL ratio, reduced the PS/TPL, PA/TPL, and (PG + CL)/TPL ratios, and did not alter the cholesterol/
TPL ratio during cell growth (Supplementary Fig. S2a,c,d,f,h,j). Unlike HepG2 cells, the TPL content decreased, 
the PE/TPL ratio increased, and the PI/TPL and SM/TPL ratios were not altered in PLC/PRF/5 cells during cell 
growth (Supplementary Fig. S2b,e,g,i). The phospholipid compositional changes during cell growth may partially 
differ among cell lines.
These observations suggested that the metabolism of all membrane phospholipid classes is dynamically 
controlled during cell growth, which may affect the proliferation, migration, morphology and functions of the 
cells. PA acts as a regulator of the mammalian target of rapamycin (mTOR), and the mTOR signaling pathway 
is involved in the control of cell growth through protein synthesis  regulation18,19,29. The Ras-specific guanine-
nucleotide exchange factor, son of sevenless (Sos), and the serine/threonine protein kinase, Raf-1, play crucial 
roles in cell growth. PA interacts with the Sos pleckstrin homology domain with high affinity and specificity, 
which is required for Ras  activation46. Activated Ras recruits Raf-1 to the plasma membrane. Raf-1 selectively 
binds to PS and PA, which is important for the translocation and activation of Raf-147. Activated Raf-1 sequen-
tially phosphorylates and activates MEK and ERK kinases. On the other hand, the SH2 domain-containing 
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phosphatase, SHP-1, suppresses cancer cell growth, and its activity is effectively stimulated by PA and  PS48. At 
the final stage of cytokinesis, the surface exposure of PE on the cleavage furrow membrane may be important for 
the completion of  cytokinesis49. PI is further phosphorylated to phosphoinositides, which regulate cell growth, 
cell survival, protein synthesis and vesicular trafficking as intracellular signaling  mediators21. The cone-shaped 
phospholipids, PE, PA and CL, reduce the activation energy for negative curvature at membrane  curves38,50,51, 
which may further lead to morphological changes of the cells and organelles. Together with cholesterol, SM 
induces the formation of lipid raft membrane microdomains, where acyl chains are well ordered and tightly 
packed, and diverse cellular processes are  activated52.
Alteration of gene expression for phospholipid biosynthesis in HepG2 cells during cell 
growth. In mammalian cells, many enzymes participate in the biosynthesis of phospholipid classes, and 
phospholipid metabolic dysfunction is involved in carcinogenesis and tumor  progression18,21,29,53. Next, to inves-
tigate how phospholipid class biosynthesis changes during cell growth, we evaluated the mRNA expression levels 
of phospholipid synthesis-related enzymes in HepG2 cells at Day 3, Day 6 and Day 12 by quantitative real-time 
PCR (qPCR) analyses (Fig. 3 and Supplementary Table S2). Among 32 candidate genes, HPRT1 and RPLP0 were 
selected as multiple reference genes (Supplementary Fig. S3). The mRNA expression levels of many enzymes at 
Day 6 and Day 12 changed compared with those at Day 3 (Fig. 3). As shown in Fig. 3a, the expression levels of 
genes for PC synthesis-related enzymes, CCTA , CCTB and CPT, in the cells at Day 6 and Day 12 significantly 
decreased compared with those at Day 3, whereas PEMT expression levels at Day 6 and Day 12 were slightly 
higher than that at Day 3. We also assessed the relative mRNA expression levels of PE and PS biosynthesis-
related enzymes (Fig. 3b). The expression levels of ECT, PSD1 and PSS1 at Day 6 and Day 12 were lower than 
those at Day 3, and there were no differences in the expression levels of EPT or PSS2 among Day 3, Day 6 and 
Figure 1.  Cell growth of HepG2 cells. Cells were seeded at a density of 5.0 × 104 cells/cm2 in six-well plates 
(Day 0). (a,b) Growth curves of HepG2 cells were determined by the measurement of total cellular DNA (a) and 
total cellular protein (b). Each point represents the mean value of three biologically independent experiments 
of duplicate measurements (mean ± S.E., n = 4). (c) Differential interference contrast images of HepG2 cells at 
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Figure 2.  Alteration of phospholipid composition in HepG2 cells. HepG2 cells were seeded at a density of 5.0 × 104 cells/cm2 in 
75-cm2 flasks and cultured in DMEM containing 10% FBS at 37 °C for the indicated days. At Day 3 (early logarithmic phase), Day 6 
(late logarithmic phase) and Day 12 (stationary phase), cellular lipids were extracted. The contents of PC, PE, PS, PA, PI, PG + CL, SM 
and cholesterol in HepG2 cells were determined by the enzymatic measurements and protein assay (see Supplementary Table S1). The 
ratios of PC/TPL (a), PE/TPL (b), PS/TPL (c), PA/TPL (d), PI/TPL (e), (PG + CL)/TPL (f), SM/TPL (g) and cholesterol/TPL (h) at Day 
3, Day 6 and Day 12 were evaluated. The total phospholipid (TPL) content (i) was calculated as the sum of PC, PE, PS, PA, PI, PG + CL 
and SM contents (mean ± S.E., n = 3, *P < 0.05, significantly different among Day 3, Day 6 and Day 12, one-way ANOVA followed by 
the Bonferroni test). (j) The phospholipid compositions in HepG2 cells at Day 3, Day 6 and Day 12 are shown as pie charts.
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Figure 3.  mRNA expression changes of phospholipid synthesis-related enzymes in HepG2 cells during cell 
growth. Relative mRNA expression of CCTA , CCTB, CPT and PEMT (a), that of ECT, EPT, PSD1, PSS1 and 
PSS2 (b), that of DGKA, DGKG, DGKD, DGKE, DGKQ, DGKK, PLD1 and PLD2 (c), that of CDS1, CDS2, PIS, 
PGS1 and CLS (d), and that of SPTLC2, SMS1 and SMS2 (e) in HepG2 cells at Day 3 (early logarithmic phase), 
Day 6 (late logarithmic phase) and Day 12 (stationary phase). The Ct value was normalized to the mean Ct value 
of HPRT1 and RPLP0. The mRNA expression relative to the mRNA expression level at Day 3 was measured 
(mean ± S.E., n = 3, *P < 0.05, significantly different among Day 3, Day 6 and Day 12, one-way ANOVA followed 
by the Bonferroni test).
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Day 12. As shown in Fig. 3c, among genes for six isoforms of DGKs (DGKA, DGKG, DGLD, DGKE, DGKQ and 
DGKK), only DGKK exhibited a significant decrease in the expression level at Day 6 and Day 12, although the 
expression of DGKB, DGKZ, DGKH and DGKI was not detected by the qPCR analysis. In contrast, the relative 
expression levels of PLD1 and PLD2 increased with cell growth. Moreover, the expression levels of CDS1 and 
CLS decreased at Day 6 and Day 12, whereas there were no significant changes in those of CDS2, PIS and PGS1 
(Fig. 3d). Among the genes for SM synthesis, HepG2 cells exhibited decreased expression levels of SMS2, but not 
SPTLC2 and SMS1, at Day 6 and Day 12 (Fig. 3e).
These results suggested that the marked changes in phospholipid class composition in HepG2 cells from the 
early logarithmic phase to stationary phase of cell growth were partly, but not entirely, due to the alteration in 
expression of phospholipid synthesis-related enzymes. The decrease in the PE ratio during cell growth (Fig. 2b) 
may be caused by the downregulation of ECT and PSD1 (Fig. 3b). The cell growth-dependent reduction of the 
PS ratio (Fig. 2c) was likely caused by PSS1 downregulation (Fig. 3b).
Alteration in phospholipid compositions of organellar membranes from HepG2 cells during 
cell growth. To further understand the relationships between cell growth and phospholipid metabolism in 
HepG2 cells, we investigated the alteration of phospholipid class compositions in intracellular organelles during 
cell growth. We isolated nuclear, microsomal and mitochondrial membrane fractions by differential ultracen-
trifugation, and confirmed the purities of these fractions by immunoblotting for nuclear pore complex protein 
98 (NUP98), calnexin (CNX) and cytochrome c oxidase subunit IV (COX IV), which are markers of the nuclear 
envelopes, ER and mitochondria, respectively (Fig. 4 and Supplementary Fig. S4).
We evaluated the phospholipid class and cholesterol compositions in the purified organellar fractions at 
Day 3 in the early logarithmic phase and at Day 12 in the stationary phase of cell growth using enzymatic fluo-
rometric assays (Figs. 5, 6, 7). In the nuclear fractions, the ratio of PC/TPL at Day 12 was decreased compared 
with that at Day 3 (Fig. 5a). Of note, the PA/TPL ratio was 1.74-fold higher in the nuclear fraction at Day 12 
than that at Day 3 (Fig. 5d). The ratio of PG + CL also slightly increased with cell growth, however, they were 
very minor components in the nuclear fraction even at Day 12 (Fig. 5f). The PE/TPL, PS/TPL, PI/TPL, SM/TPL 
and cholesterol/TPL ratios in the nuclear fractions did not change during cell growth (Fig. 5b,c,e,g,h). In the 
nuclear fraction from the cells at Day 3 in the early logarithmic phase, the most abundant phospholipid was PC, 
followed in descending order by PE, PI, PA, SM, PS and PG + CL, whereas PA became the third most abundant 
phospholipid component in the nuclear fraction at Day 12 in the stationary phase (Fig. 5i).
The microsomal fraction includes vesicles derived from the ER and Golgi apparatus, which are the predomi-
nant sites of phospholipid and cholesterol  biosyntheses26,36,54. In the microsomal fractions, the ratios of PE, PS, 
PA, PI and cholesterol to TPL did not significantly change from Day 3 in the early logarithmic phase to Day 12 
in the stationary phase (Fig. 6b–e,h). The microsomal fraction at Day 12 had a slightly lower PC/TPL ratio than 
that at Day 3 (Fig. 6a). Similar to the nuclear membranes, the increase in the PG + CL ratio during cell growth 
was significant in the microsomal membranes, but the ratio remained quite low even at Day 12 (Fig. 6f). Interest-
ingly, the SM/TPL ratio in the microsomal fraction was 1.35-fold higher at Day 12 than at Day 3 (Fig. 6g). In the 
microsomal fraction from the cells at Day 3 in the early logarithmic phase, the phospholipid class ratios, from 
highest to lowest, were PC > PE > PA > PS ≥ SM ≥ PI > PG + CL, whereas the ratio of SM became higher than that 
of PS and similar to that of PA at Day 12 in the stationary phase (Fig. 6i).
In the mitochondrial fraction during cell growth, the PE/TPL ratio increased, but the PS/TPL ratio decreased 
(Fig. 7b,c). On the other hand, the PC/TPL ratio only slightly decreased, and the ratios of PA, PI, SM and choles-
terol to TPL did not significantly change from Day 3 in the early logarithmic phase to Day 12 in the stationary 
phase (Fig. 7a,d,e,g,h). In contrast to the nuclear and microsomal fractions, there was no significant difference in 
the mitochondrial (PG + CL)/TPL ratios between Day 3 and Day 12, but the mitochondrial fractions contained 
high ratios of PG + CL (Fig. 7f). In the mitochondrial fractions, the most abundant phospholipid was PC, fol-
lowed in descending order by PE, SM, PA, PS, PG + CL and PI at Day 3 in the early logarithmic phase, whereas 
the ratio of PS became lower at Day 12 in the stationary phase (Fig. 7i).
Although phospholipids are synthesized mainly in the ER and mitochondria in mammalian cells, PC and PA 
are also produced in the nuclear  envelopes18,26,29. CCTs are rate-limiting enzymes in the CDP-choline pathway for 
Figure 4.  Isolation of organellar fractions from HepG2 cells. The whole-cell (Whole), purified nuclear (Nuc), 
microsomal (Mic) and mitochondrial (Mit) fractions (2.0 μg of protein) were separated by 7% or 15% SDS-
PAGE and then immunoblotted with anti-NUP98, anti-CNX or anti-COX IV antibody. NUP98, CNX and COX 
IV are markers of the nucleus, ER and mitochondria, respectively. Three blots were cropped from different 
PVDF membranes. The full-length blots are presented in Supplementary Fig. S4.
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PC  biosynthesis26. The cell growth-related decrease in the PC ratio in the nuclear envelops may be explained by 
the down-regulation of CCTA (Figs. 3a, 5a) because CCTα, but not CCTβ, is localized primarily in the  nucleus26. 
CPT is an integral ER membrane  protein26. Thus, the reduction in the microsomal PC ratio in the stationary 
phase may be caused by lower expression levels of CCTB and/or CPT. In contrast to the nuclear, microsomal and 
mitochondrial fractions, the PC ratio in the whole cells slightly but significantly increased during cell growth 
(Fig. 2a), which may be caused by the increase in the PC ratio in other cellular compartments such as the plasma 
membrane.
Figure 5.  Alteration of nuclear phospholipid composition in HepG2 cells during cell growth. HepG2 cells were 
seeded at a density of 5.0 × 104 cells/cm2 in 150-cm2 flasks and cultured in DMEM containing 10% FBS at 37 °C 
for the indicated days. At Day 3 (early logarithmic phase) and Day 12 (stationary phase), nuclear fractions were 
isolated from the cells, and nuclear lipids were extracted. The total phospholipid (TPL) content was calculated 
as the sum of PC, PE, PS, PA, PI, PG + CL and SM contents. The ratios of PC/TPL (a), PE/TPL (b), PS/TPL 
(c), PA/TPL (d), PI/TPL (e), (PG + CL)/TPL (f), SM/TPL (g) and cholesterol/TPL (h) in the nuclear fractions 
purified from the cells at Day 3 and Day 12 were determined by the enzymatic measurements (mean ± S.E., 
n = 3, *P < 0.05, significantly different between Day 3 and Day 12, unpaired two-tailed Student’s t-test). (i) The 
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The growth-arrested cells exhibit a higher coupling state of oxidative phosphorylation than the proliferating 
 cells55. During cell growth to confluence, there is an increase in the proportion of mitochondria to be shorter 
bead-like forms and more randomly  aligned56. Mitochondrial cristae are tube-like extensions of the mitochon-
drial inner membrane, which is highly enriched in negative curvature phospholipids, PE and  CL57. Mitochondrial 
PE is essential for the correct morphology of  mitochondria58,59. PE is produced from PS by PSD in mitochondrial 
inner  membranes27,35. As shown in Figs. 3b, 7b,c, the mitochondrial PE/TPL ratio increased and the mitochon-
drial PS/TPL ratio decreased with cell growth despite PSD1 downregulation, raising the possibility that the 
Figure 6.  Alteration of microsomal phospholipid composition in HepG2 cells during cell growth. HepG2 cells 
were seeded at a density of 5.0 × 104 cells/cm2 in 150-cm2 flasks and cultured in DMEM containing 10% FBS 
at 37 °C for the indicated days. At Day 3 (early logarithmic phase) and Day 12 (stationary phase), microsomal 
fractions were isolated from the cells, and microsomal lipids were extracted. The total phospholipid (TPL) 
content was calculated as the sum of PC, PE, PS, PA, PI, PG + CL, and SM contents. The ratios of PC/TPL (a), 
PE/TPL (b), PS/TPL (c), PA/TPL (d), PI/TPL (e), (PG + CL)/TPL (f), SM/TPL (g) and cholesterol/TPL (h) 
in the microsomal fractions purified from the cells at Day 3 and Day 12 were determined by the enzymatic 
measurements (mean ± S.E., n = 3, *P < 0.05, significantly different between Day 3 and Day 12, unpaired two-
tailed Student’s t-test). (i) The phospholipid compositions of the purified microsomal fractions from HepG2 
cells at Day 3 and Day 12 are shown as pie charts.
9
Vol.:(0123456789)
Scientific Reports |         (2021) 11:2731  | https://doi.org/10.1038/s41598-021-81733-3
www.nature.com/scientificreports/
export of mitochondrial PE to other organellar membranes and the import of PS to mitochondrial membranes 
were suppressed in the stationary phase. The counter-transport of PS and PI(4)P between the ER and plasma 
membranes is mediated by oxysterol-binding protein-related proteins 5 and 8, which have also been reported to 
be localized to the ER-mitochondria contact  sites60,61. However, the mechanism underlying the translocation of 
PE and PS between mitochondria and other organelles is largely unclear.
The production of PA from PC is catalyzed by the membrane-bound PLDs. PLD1 is localized to the peri-
nuclear region, Golgi, ER and late endosomes, whereas PLD2 is localized to the plasma  membrane29,50. The 
Figure 7.  Alteration of mitochondrial phospholipid composition in HepG2 cells during cell growth. HepG2 
cells were seeded at a cell density of 5.0 × 104 cells/cm2 in 150-cm2 flasks and cultured in DMEM containing 
10% FBS at 37 °C for the indicated days. At Day 3 (early logarithmic phase) and Day 12 (stationary phase), 
mitochondrial fractions were isolated from the cells and mitochondrial lipids were extracted. The total 
phospholipid (TPL) content was calculated as the sum of PC, PE, PS, PA, PI, PG + CL, and SM contents. The 
ratios of PC/TPL (a), PE/TPL (b), PS/TPL (c), PA/TPL (d), PI/TPL (e), (PG + CL)/TPL (f), SM/TPL (g) and 
cholesterol/TPL (h) in the mitochondrial fractions purified from the cells at Day 3 and Day 12 were determined 
by the enzymatic measurements (mean ± S.E., n = 3, *P < 0.05, significantly different between Day 3 and Day 12, 
unpaired two-tailed Student’s t-test). (i) The phospholipid compositions of the purified microsomal fractions 
from HepG2 cells at Day 3 and Day 12 are shown as pie charts.
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increase in the ratio of PA in nuclear membranes during cell growth (Fig. 5d) may be due to the upregulation 
of PLD1. DGK isoforms also function in the production of PA around nuclear envelopes. Most DGK isoforms 
are cytosolic in mammalian cells, but the translocations of DGKα, DGKγ, DGKθ, DGKζ and DGKι from the 
cytosol to the nucleus regulate their spatiotemporal  activation18. In HepG2 cells, the mRNA expression levels of 
DGKA, DGKG and DGKQ were not regulated by cell growth (Fig. 3c), and those of DGKZ and DGKI were not 
detectable. Thus, DGKs were likely not responsible for the increase in the PA ratio in nuclear envelopes in the 
stationary phase of cell growth.
Mitochondria are exclusive sites for the biosynthesis of PG and CL, which are required for mitochondrial 
energy  production20,33,35. Cell growth had no significant effect on the mitochondrial ratio of PG + CL despite the 
downregulation of CLS (Figs. 3d, 7f). Therefore, the ratio of PG + CL in mitochondrial membranes was suggested 
to be strictly maintained during the cell growth, which may be crucial for the correct mitochondrial functions.
The increase in the microsomal SM ratio during cell growth is shown in Fig. 6g. On the other hand, SMS2 was 
down-regulated, and SPTLC2 and SMS1 were constantly expressed during cell growth (Fig. 3e). SM is formed 
from ceramide and the phosphocholine group of PC by SMS1 at the Golgi membranes or by SMS2 at the plasma 
 membrane36. However, the regulatory mechanism to translocate SM into the ER remains unclear.
Sterol regulatory element-binding proteins (SREBPs) form complexes with SREBP-cleavage activating pro-
tein (SCAP) at the ER membranes and control the membrane cholesterol  homeostasis62. When the cholesterol 
concentration increases in the ER membranes, the binding of cholesterol to the sterol-sensing domain of SCAP 
induces the association of SCAP with Insig, which prevents the transport of SREBP/SCAP complexes to the 
Golgi and the proteolytic activation of  SREBP62. In HepG2 cells, the ratios of cholesterol to TPL were different 
among the nuclear, microsomal and mitochondrial membranes (~ 15%, ~ 36% and ~ 55%, respectively), but the 
cholesterol ratio in each membrane fraction was not affected by the cell growth (Figs. 5, 6, 7). It is possible that 
machineries to tightly regulate the membrane cholesterol ratio exist in the nuclear envelopes and mitochondria 
in addition to the ER.
We have previously investigated the relationships between expression levels of phospholipid synthesis-related 
enzymes and phospholipid class composition using stably transfected HEK293 cells. The increase in PEMT 
expression leads to the increased PC content and the decreased PE  content40. The cellular PS content increases 
due to the overexpression of  PSS141. The increased expression of PGS1 results in the elevated mitochondrial 
content of PG + CL43. The increase in the expression of PIS, CDS1 or CDS2 induces an increase in the PI ratio in 
microsomes, but not in  mitochondria44. Thus, during cell growth, the altered expression levels of phospholipid 
synthesis-related enzymes may affect the cellular and/or organellar phospholipid class composition in HepG2 
cells.
In conclusion, by using enzymatic fluorometric methods for quantifying phospholipid classes, we demon-
strated the changes in phospholipid compositions in HepG2 cells and their intracellular organelles during cell 
growth using enzymatic fluorometric methods to quantify phospholipid classes. All phospholipid class ratios, 
but not the cholesterol ratio, markedly changed depending on cell growth. The higher PA ratio and lower PC 
ratio in the nuclear membrane, the higher SM ratio in the microsomal membrane and the higher PE ratio and 
lower PS ratio in the mitochondrial membrane were characteristic of the stationary phase compared with the 
early logarithmic phase. In addition, qPCR analysis revealed that the mRNA expression levels of many phospho-
lipid synthesis-related enzymes, particularly CCTA , CCTB, CPT, ECT, PSD1, PSS1, DGKK, PLD1, PLD2, CLS 
and SMS2, were affected by cell growth. This study provides fundamental and valuable information to further 
understand the mechanisms underlying cancer cell growth and lipid metabolism.
Methods
Cell culture. HepG2 cells were purchased from Riken BioResource Center (Tsukuba, Japan). HepG2 cells 
were cultured in DMEM containing 10% heat-inactivated fetal bovine serum (FBS) in 5%  CO2 at 37 °C, and con-
fluent cells were subcultured at a split ratio of 1:5 after trypsin–EDTA treatment (Nacalai Tesque, Kyoto, Japan). 
For experiments, HepG2 cells were seeded at a density of 5.0 × 104 cells/cm2 in six-well plates (4.8 × 105 cells/
well) (Thermo Fisher Scientific, Rockford, IL, USA), in 75-cm2 flasks (3.75 × 106 cells/flask) (TPP Techno Plastic 
Products, Trasadingen, Switzerland) or in 150-cm2 flasks (7.50 × 106 cells/flask) (TPP Techno Plastic Products), 
and incubated in DMEM with 10% FBS.
Cell growth experiments. HepG2 cells were seeded at a density of 5.0 × 104 cells/cm2 in six-well plates and 
cultured in DMEM with 10% FBS for up to 14 days. The culture medium was changed every other day. Cells 
were washed and scraped with cold phosphate-buffered saline (PBS). To prepare whole cell lysates, cells were 
sonicated using an Ultrasonic Disruptor UR-20P (Tomy Seiko, Tokyo, Japan) and lysed with 1% Triton X-100 
in PBS. The concentrations of total DNA and protein in cell lysates were measured using a Quant-iT dsDNA BR 
Assay Kit (Invitrogen, Carlsbad, CA, USA) and a BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL, 
USA), respectively.
RNA isolation and cDNA synthesis. HepG2 cells were seeded at a density of 5.0 × 104 cells/cm2 in six-
well plates and cultured in DMEM with 10% FBS for 3, 6 and 12 days. Cells were harvested and pelleted followed 
by total RNA isolation using an SV Total RNA Isolation System (Promega, Madison, WI). The concentration 
of total RNA was measured using a Quant-iT RNA BR Assay Kit (Invitrogen, Carlsbad, CA, USA). To obtain 
cDNA, 0.5 μg of total RNA was used as the template for reverse transcription using ReverTra Ace qPCR RT 
Master Mix with gDNA Remover (Toyobo, Osaka, Japan) according to the manufacturer’s instructions. cDNA 
was diluted 1:20 in nuclease-free water before being used as a template for qPCR.
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qPCR. TaqMan Custom Array Fast Plate (Applied Biosystems, Foster City, CA, USA) was used to evaluate the 
expression levels of phospholipid synthesis-related enzymes in HepG2 cells. TaqMan Gene Expression assays in 
the plate are shown in Supplementary Table S2. Among 32 candidate genes, HPRT1 and RPLP0 were selected as 
reference genes using the TaqMan Array Human Endogenous Control Plate, Fast 96-well (Applied Biosystems) 
by NormFinder and BestKeeper  algorithms63,64 (Supplementary Fig. S2). qPCR was carried out using the StepO-
nePlus Real-Time PCR System and StepOne Software v2.3 (Applied Biosystems). PCR reactions were performed 
with cDNA as the template and with TaqMan Fast Advanced Master Mix (Applied Biosystems). The cycler 
program was (i) 2 min at 50 °C, (ii) 20 s at 95 °C, and (iii) 40 cycles of 1 s at 95 °C and 20 s at 60 °C. The relative 
mRNA expression was calculated by the comparative Ct (ΔΔCt)  method65. The values of the threshold cycle (Ct) 
were obtained from three separate experiments (n = 3), and normalized to the mean of Ct values of HPRT1 and 
RPLP0. The mRNA expression relative to that at Day 3  (2−ΔΔCt) was calculated.
Measurement of phospholipid and cholesterol contents. To measure the contents of cellular phos-
pholipids and cholesterol, HepG2 cells were seeded at a density of 5.0 × 104 cells/cm2 in 75-cm2 flasks and cul-
tured in DMEM with 10% FBS for 3, 6 and 12 days. Cells were washed, scraped with cold PBS and sonicated to 
prepare whole-cell homogenates. To measure the contents of phospholipids and cholesterol in purified nuclear, 
mitochondrial and microsomal fractions, cells were seeded at a density of 5.0 × 104 cells/cm2 in 150-cm2 flasks 
and cultured in DMEM with 10% FBS for 3 and 12 days. Cells were washed with cold PBS and homogenized 
in the homogenization buffer (225 mM mannitol, 75 mM sucrose, 30 mM Tris–HCl and 100 μM EGTA, pH 
7.4) using a Potter-Elehjem homogenizer, and the homogenate was centrifuged for 5 min at 600×g to obtain the 
pellet containing nuclei and the supernatant containing mitochondria and microsomes. Purified nuclear, mito-
chondrial and microsomal fractions were isolated from six flasks of cells at Day 3 and from one flask of cells at 
Day 12 according to the method previously  described66,67. Purified organellar fractions were washed once and 
suspended in 5 mM HEPES buffer (pH 7.4).
Cellular and organellar lipids were extracted by the method of Folch as described  previously44,68. Lipid extract 
was dissolved by the addition of 1% Triton X-100. The contents of PC, PE, PS, PA, PI, PG + CL, SM and cholesterol 
in the extracts were quantified by enzymatic assays using combinations of specific enzymes and Amplex Red as 
previously  described13,38–41,43,44. The total phospholipid (TPL) content was calculated as the sum of PC, PE, PS, 
PA, PI, PG + CL and SM contents.
We confirmed the recovery of phospholipid classes after the Folch extraction method (see Supplementary 
Methods). As depicted in Supplementary Table S3, PC, PE, PG, CL and SM were almost completely recovered 
by the Folch method. Although the majority (> 80%) of PS, PA and PI molecules were recovered after the Folch 
method, the cellular contents of PS, PA and PI may have been slightly underestimated. Lysophosphatidylcho-
line and sphingosylphosphocholine are not detected by the enzymatic measurements, but lysophosphatidyle-
thanol (LPE), lysophosphatidylserine (LPS), lysophosphatidic acid (LPA), lysophosphatidylinositol (LPI) and 
lysophosphatidylglycerol (LPG) can be measured by the enzymatic fluorometric assay for PE, PS, PA, PI and 
PG + CL,  respectively24. After the Folch method, LPS, LPA, LPI and LPG were almost fully removed from the 
extract, whereas LPE was substantially recovered (Supplementary Table S3). It has been reported that, using 
supercritical fluid chromatography with a charged aerosol detector, LPE, but not PE, is not identified in the 
HepG2  extracts69. Therefore, the amounts of lysophospholipid classes are probably small enough to be ignored 
in the cellular lipid extracts.
Immunoblotting. Whole cell homogenates and organellar fractions were lysed with 5 mM HEPES buffer 
containing 1% Triton X-100 and protease inhibitors (100 μg/ml (p-amidinophenyl)methanesulfonyl fluoride, 
10 μg/ml leupeptin and 2 μg/ml aprotinin). Immunoblotting was performed as previously  described44. The blot-
ted PVDF membranes were incubated with monoclonal anti-NUP98 antibody C39A3 (1:2000 dilution; Cell 
Signaling Technology, Danvers, MA, USA), monoclonal anti-COX IV antibody 3E11 (1:20,000; Cell Signal-
ing Technology) or polyclonal anti-CNX antibody (1:10,000; Enzo Life Sciences, Farmingdale, NY, USA), fol-
lowed by incubation with horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (1:5000; Invitrogen) 
or HRP-conjugated goat anti-rabbit IgG (1:10,000; Merck Millipore). The image was obtained using Amersham 
ECL Prime Western Blotting Detection Reagent and an ImageQuant LAS 4000 mini biomolecular imager (GE 
Healthcare, Buckinghamshire, UK).
Statistical analysis. The results are given as the means ± S.E.s of three biologically independent experi-
ments unless otherwise indicated. Statistical significance was assessed by the unpaired Student’s t-test or one-
way ANOVA followed by the Bonferroni test. Differences were considered significant at P < 0.05 (two-tailed).
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